Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea
Original source: https://www.investing.com/news/stock-market-news/lillys-weightloss-drug-zepbound-wins-us-fda-approval-for-sleep-apnea-3785420
Read More »US FDA puts Kezar Life Sciences’ lupus treatment trial on hold after patient deaths
Original source: https://www.investing.com/news/stock-market-news/us-fda-puts-clinical-hold-on-kezar-life-sciences-lupus-treatment-trial-3649995
Read More »FDA authorizes first OTC hearing aid software to be used in Apple’s AirPods Pro
Original source: https://www.investing.com/news/stock-market-news/fda-authorizes-first-otc-hearing-aid-software-to-be-used-in-airpods-pro-headphones-3613871
Read More »US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug
Original source: https://www.investing.com/news/stock-market-news/us-fda-warns-of-dosing-errors-with-compounded-versions-of-novos-weight-loss-drugs-3539477
Read More »US FDA approves Merck’s pneumococcal vaccine for adults
Original source: https://www.investing.com/news/stock-market-news/us-fda-approves-mercks-pneumococcal-vaccine-for-adults-3487789
Read More »US FDA panel votes against first MDMA-based PTSD treatment
Original source: https://www.investing.com/news/stock-market-news/fda-panel-to-review-psychedelic-drug-mdma-for-first-time-3469436
Read More »SmallCapFirm.com Commentary: 5 Stocks That Shining on November 11, 2023
In today’s dynamic stock market, individuals seeking opportunities for potential gains are always on the lookout. While the market landscape can be unpredictable, staying informed about the latest developments and…
Read More »FEMY Up 346.32% On News Of FDA Clearance For FemaSeed Infertility Treatment.
FEMY Closed Up 346.32% On News Of FDA Clearance For FemaSeed Infertility Treatment. Femasys, Inc., (NASDAQ:FEMY) saw huge growth today on news of receiving U.S. FDA clearance for FemaSeed®,…
Read More »US FDA approves Biogen-Sage Therapeutics pill for postpartum depression
Original source: https://www.investing.com/news/stock-market-news/us-fda-approves-biogensage-therapeutics-pill-for-clinical-depression-3145941
Read More »